- Amino-PEG10-amine
-
- $0.00 / 100mg
-
2026-04-21
- CAS:928292-69-7
- Min. Order:
- Purity:
- Supply Ability: 10g
- 3,6,9,12,15,18,21,24,27,30-decaoxadotriacontane-1,32-diamine
-
- $0.00 / 1g
-
2026-02-05
- CAS:928292-69-7
- Min. Order: 1g
- Purity: 98%
- Supply Ability: 1g/bottle, 10g/bottle, 100g/bottle
- Amino-PEG10-amine
-
- $0.00 / 250mg
-
2025-06-07
- CAS:928292-69-7
- Min. Order: 250mg
- Purity: >98.00%
- Supply Ability: 250mg
|
| | 3,6,9,12,15,21,24,27,30-Decaoxadotriacontane-1,32-diaMine Basic information |
| Product Name: | 3,6,9,12,15,21,24,27,30-Decaoxadotriacontane-1,32-diaMine | | Synonyms: | 3,6,9,12,15,21,24,27,30-Decaoxadotriacontane-1,32-diaMine;H2N-PEG10-CH2CH2NH2;3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diaMine;Amino-PEG10-Amine;NH2-PEG10-NH2;H2N-PEG10-CH2CH2NH2/3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontane-1,32-diamine;2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanamine;H2N-PEG11-NH2 (HQ) | | CAS: | 928292-69-7 | | MF: | C22H48N2O10 | | MW: | 500.62 | | EINECS: | | | Product Categories: | peg | | Mol File: | 928292-69-7.mol |  |
| | 3,6,9,12,15,21,24,27,30-Decaoxadotriacontane-1,32-diaMine Chemical Properties |
| Boiling point | 560.0±45.0 °C(Predicted) | | density | 1.082±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C, protect from light | | form | Solid-Liquid Mixture | | pka | 9.04±0.10(Predicted) | | color | Colorless to off-white |
| | 3,6,9,12,15,21,24,27,30-Decaoxadotriacontane-1,32-diaMine Usage And Synthesis |
| Description | Amino-PEG10-Amine is a crosslinking reagent with two amino groups on both sides. The hydrophilic PEG spacer increases solubility in aqueous media. The amino groups are reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. | | Uses | Amino-PEG10-amine, a PEG-based PROTAC linker used to combine two mono diethylstilbestrol (DES)-based ligands, provides an alternative strategy for preparing more selective and active ER antagonists for endocrine therapy of breast cancer[1]. | | IC 50 | PEGs | | References | [1] Shan M, et al. Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. ACS Chem Biol. 2013 Apr 19;8(4):707-15. DOI:10.1021/cb3006243 |
| | 3,6,9,12,15,21,24,27,30-Decaoxadotriacontane-1,32-diaMine Preparation Products And Raw materials |
|